{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T16:20:06Z","timestamp":1772900406063,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.pathol.2022.01.008","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T20:57:21Z","timestamp":1651265841000},"page":"591-598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Design and validation of an LC-MS\/MS method for simultaneous quantification of asymmetric dimethylguanidino valeric acid, asymmetric dimethylarginine and symmetric dimethylarginine in human plasma"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7658-3383","authenticated-orcid":false,"given":"Paul","family":"Bonnitcha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3085-5627","authenticated-orcid":false,"given":"David","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5797-6854","authenticated-orcid":false,"given":"Michael","family":"Fitzpatrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Ireland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Van Long","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen Chin","family":"Koay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"O'Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2022.01.008_bib1","first-page":"1124","article-title":"Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality","volume":"43","author":"Boeger","year":"2005","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.pathol.2022.01.008_bib2","doi-asserted-by":"crossref","first-page":"12315","DOI":"10.3390\/ijms131012315","article-title":"Asymmetric dimethylarginine as a surrogate marker of endothelial dysfunction and cardiovascular risk in patients with systemic rheumatic diseases","volume":"13","author":"Dimitroulas","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pathol.2022.01.008_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/09513590.2016.1203893","article-title":"Evaluation of cardiac risk marker levels in obese and non-obese patients with polycystic ovaries","volume":"33","author":"Elci","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.pathol.2022.01.008_bib4","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s11255-013-0439-6","article-title":"Endothelial dysfunction, inflammation and malnutrition markers as predictors of mortality in dialysis patients: multimarker approach","volume":"45","author":"Ignjatovic","year":"2013","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.pathol.2022.01.008_bib5","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.eururo.2011.02.008","article-title":"Relationship of asymmetric dimethylarginine with penile Doppler ultrasound parameters in men with vasculogenic erectile dysfunction","volume":"59","author":"Ioakeimidis","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.pathol.2022.01.008_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-50778-w","article-title":"ADMA as a possible marker of endothelial damage. A study in young asymptomatic patients with cerebral small vessel disease","volume":"9","author":"Janes","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.pathol.2022.01.008_bib7","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1111\/j.1523-1755.2005.00680.x","article-title":"Plasma asymmetric dimethylarginine (ADMA) concentration is independently associated with carotid intima-media thickness and plasma soluble vascular cell adhesion molecule-1 (sVCAM-1) concentration in patients with mild-to-moderate renal failure","volume":"68","author":"Nanayakkara","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.pathol.2022.01.008_bib8","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1161\/STROKEAHA.109.557116","article-title":"Association of plasma ADMA levels with MRI markers of vascular brain injury","volume":"40","author":"Pikula","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.pathol.2022.01.008_bib9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrneph.2011.31","article-title":"The role of asymmetric and symmetric dimethylarginines in renal disease","volume":"7","author":"Schwedhelm","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.pathol.2022.01.008_bib10","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/humupd\/dmr025","article-title":"Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome","volume":"17","author":"Toulis","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.pathol.2022.01.008_bib11","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1055\/s-0033-1353183","article-title":"Asymmetric dimethylarginine (ADMA) and soluble vascular cell adhesion molecule 1 (sVCAM-1) as circulating markers for endothelial dysfunction in patients with pheochromocytoma","volume":"121","author":"Vasilev","year":"2013","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.pathol.2022.01.008_bib12","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000507862","article-title":"Symmetric dimethylarginine as a secondary prevention biomarker of chronic kidney disease","volume":"144","author":"Ostojic","year":"2020","journal-title":"Nephron"},{"key":"10.1016\/j.pathol.2022.01.008_bib13","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s13054-018-2090-1","article-title":"Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsis survival","volume":"22","author":"Winkler","year":"2018","journal-title":"Crit Care"},{"key":"10.1016\/j.pathol.2022.01.008_bib14","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1681\/ASN.2005101119","article-title":"Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease","volume":"17","author":"Bode-Boeger","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.pathol.2022.01.008_bib15","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1172\/JCI95995","article-title":"Dimethylguanidino valeric acid is a marker of liver fat and predicts diabetes","volume":"127","author":"O'Sullivan","year":"2017","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pathol.2022.01.008_bib16","article-title":"Dimethylguanidino valerate: a lifestyle-related metabolite associated with future coronary artery disease and cardiovascular mortality","volume":"8","author":"Ottosson","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.pathol.2022.01.008_bib17","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3390\/cells10050980","article-title":"Metabolic signatures in coronary artery disease: results from the BioHEART-CT study","volume":"10","author":"Vernon","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.pathol.2022.01.008_bib18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3390\/metabo10080315","article-title":"Plasma metabolites associate with all-cause mortality in individuals with type 2 diabetes","volume":"10","author":"Ottosson","year":"2020","journal-title":"Metabolites"},{"key":"10.1016\/j.pathol.2022.01.008_bib19","doi-asserted-by":"crossref","first-page":"e509","DOI":"10.1152\/ajpendo.00207.2020","article-title":"Nutritional and metabolic regulation of the metabolite dimethylguanidino valeric acid: an early marker of cardiometabolic disease","volume":"319","author":"Wali","year":"2020","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.pathol.2022.01.008_bib20","series-title":"Requirements for the Development and Use of In-House In Vitro Diagnostic Medical Devices (IVDs): (Fourth Edition 2018)","year":"2018"},{"key":"10.1016\/j.pathol.2022.01.008_bib21","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/jlac.198319830917","article-title":"Umwandlung von o-guanidino- und o-ureido-a-aminosauren in a-ketosauren und deren heterocyclische folgeprodukte","author":"Klein","year":"1983","journal-title":"Liebigs Ann Chem"},{"key":"10.1016\/j.pathol.2022.01.008_bib22","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.clinbiochem.2004.11.007","article-title":"Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry","volume":"38","author":"Taylor","year":"2005","journal-title":"Clin Biochem"},{"key":"10.1016\/j.pathol.2022.01.008_bib23","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal Chem"},{"key":"10.1016\/j.pathol.2022.01.008_bib24","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/(SICI)1097-0231(19990630)13:12<1175::AID-RCM639>3.0.CO;2-0","article-title":"The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds","volume":"13","author":"Bonfiglio","year":"1999","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1016\/j.pathol.2022.01.008_bib25","series-title":"CLSI document EP05-A3:2014","article-title":"Evaluation of Precision of Quantitative Measurement Procedures","year":"2014"},{"key":"10.1016\/j.pathol.2022.01.008_bib26","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00216-011-5462-9","article-title":"A\u00a0simple and fast liquid chromatography-tandem mass spectrometry method for measurement of underivatized L-arginine, symmetric dimethylarginine, and asymmetric dimethylarginine and establishment of the reference ranges","volume":"402","author":"El-Khoury","year":"2012","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.pathol.2022.01.008_bib27","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ab.2011.08.044","article-title":"Detection and quantification of \u03b1-keto-\u03b4-(NG,NG-dimethylguanidino)valeric acid: a metabolite of asymmetric dimethylarginine","volume":"419","author":"Martens-Lobenhoffer","year":"2011","journal-title":"Anal Biochem"},{"key":"10.1016\/j.pathol.2022.01.008_bib29","series-title":"Evaluation of the Linearity of quantitative measurement procedures: a statistical approach; approved guideline. CLSI document EP06-A","year":"2003"},{"key":"10.1016\/j.pathol.2022.01.008_bib30","series-title":"Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory","year":"2010"},{"key":"10.1016\/j.pathol.2022.01.008_bib31","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1373\/clinchem.2010.155895","article-title":"Simultaneous determination of 6 L-arginine metabolites in human and mouse plasma by using hydrophilic-interaction chromatography and electrospray tandem mass spectrometry","volume":"57","author":"Brown","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.pathol.2022.01.008_bib32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jchromb.2005.09.023","article-title":"Comparison of HPLC method and commercial ELISA assay for asymmetric dimethylarginine (ADMA) determination in human serum","volume":"828","author":"Valtonen","year":"2005","journal-title":"J\u00a0Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.pathol.2022.01.008_bib33","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/clinchem\/43.8.1421","article-title":"Amino acid determination in biological fluids by automated ion-exchange chromatography: performance of Hitachi L-8500A","volume":"43","author":"Le Boucher","year":"1997","journal-title":"Clin Chem"},{"key":"10.1016\/j.pathol.2022.01.008_bib34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jchromb.2006.11.052","article-title":"High-throughput liquid chromatographic-tandem mass spectrometric determination of arginine and dimethylated arginine derivatives in human and mouse plasma","volume":"851","author":"Schwedhelm","year":"2007","journal-title":"J\u00a0Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.pathol.2022.01.008_bib35","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1161\/ATVBAHA.109.185645","article-title":"Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition","volume":"29","author":"Wang","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pathol.2022.01.008_bib36","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1681\/ASN.2007040461","article-title":"ADMA levels correlate with proteinuria, secondary amyloidosis, and endothelial dysfunction","volume":"19","author":"Yilmaz","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.pathol.2022.01.008_bib37","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2337\/dc07-1762","article-title":"Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy","volume":"31","author":"Lajer","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pathol.2022.01.008_bib38","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1515\/cclm.2011.679","article-title":"Plasma symmetric dimethylarginine reference limits from the Framingham offspring cohort","volume":"49","author":"Schwedhelm","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.pathol.2022.01.008_bib40","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s00726-019-02765-8","article-title":"Establishment of reference values for the lysine acetylation marker Ne-acetyllysine in small volume human plasma samples by a multi-target LC-MS\/MS method","volume":"51","author":"Gessner","year":"2019","journal-title":"Amino Acids"},{"key":"10.1016\/j.pathol.2022.01.008_bib41","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1373\/clinchem.2009.124263","article-title":"Asymmetric dimethylarginine reference intervals determined with liquid chromatography-tandem mass spectrometry: results from the Framingham offspring cohort","volume":"55","author":"Schwedhelm","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.pathol.2022.01.008_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177493","article-title":"The issue of plasma asymmetric dimethylarginine reference range - a systematic review and meta-analysis","volume":"12","author":"Nemeth","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.pathol.2022.01.008_bib43","first-page":"28","article-title":"Plasma asymmetric dimethylarginine levels in healthy people","volume":"53","author":"Deneva-Koycheva","year":"2011","journal-title":"Folia Med (Plovdiv)"},{"key":"10.1016\/j.pathol.2022.01.008_bib44","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cca.2007.07.006","article-title":"Reference values for plasma concentrations of asymmetrical dimethylarginine (ADMA) and other arginine metabolites in men after validation of a chromatographic method","volume":"384","author":"Meinitzer","year":"2007","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.pathol.2022.01.008_bib45","series-title":"ADMA\/SDMA. 31","author":"Cleveland-Heartlab","year":"2015"},{"key":"10.1016\/j.pathol.2022.01.008_bib46","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pathol.2018.09.062","article-title":"Nonfasting versus fasting lipid profile for cardiovascular risk prediction","volume":"51","author":"Langsted","year":"2019","journal-title":"Pathology"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302522001210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302522001210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T13:39:35Z","timestamp":1710509975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302522001210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0031302522001210"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2022.01.008","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and validation of an LC-MS\/MS method for simultaneous quantification of asymmetric dimethylguanidino valeric acid, asymmetric dimethylarginine and symmetric dimethylarginine in human plasma","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2022.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}